Navigation Links
Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
Date:5/17/2013

there may be potential to reduce disease progression, and thereby slow the decline of lung function. Nintedanib is also in clinical development and under evaluation as a possible treatment option for cancer, including non-small cell lung cancer, ovarian cancer, colorectal cancer and hepatocellular carcinoma.

About Olodaterol
Olodaterol is an investigational long-acting beta2-agonist (LABA) currently being studied as a once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. Olodaterol's efficacy as a once-daily bronchodilator in patients with COPD is being investigated in a robust clinical trial program, which has been conducted in a patient population representative of those seen in clinical practice.

About Spiriva® HandiHaler® (tiotropium bromide inhalation powder)
SPIRIVA HandiHaler is a prescription medicine used once every day (a maintenance medicine) to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing airways. COPD includes chronic bronchitis, emphysema or both.

SPIRIVA HandiHaler also reduces the likelihood of flare-ups (exacerbations), which are worsening of COPD symptoms (COPD exacerbations). A COPD exacerbation or flare-up is defined as an increase or new onset of more than one COPD symptom such as cough, mucus, shortness of breath and wheezing that requires medicine beyond your rescue medicine.

Important Safety Information for Spiriva® HandiHaler® (tiotropium bromide inhalation powder)Do not use SPIRIVA HandiHaler if you are allergic to tiotropium or ipratropium (e.g., Atrovent®) or any of the ingredients in SPIRIVA. If your breathing suddenly worsens, your face, throat, lips or tongue swells, you get hives, itching or rash, stop taking SPIRIVA and seek immediate medical help.

Spiriva® HandiHaler® (tiotropium bromide inhalation
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Boehringer Ingelheim Announces Launch of GLORIA™-AF Registry in Newly-Diagnosed Patients with Non-Valvular Atrial Fibrillation
2. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
3. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
4. Results of Phase II Study of Boehringer Ingelheims Investigational Bronchodilator for COPD Presented at 2012 ATS International Conference
5. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
6. Lilly and Boehringer Ingelheim Present Data at the 72nd American Diabetes Association Scientific Sessions® from Phase II Studies Comparing Investigational Novel Basal Insulin to Insulin Glargine
7. Boehringer Ingelheim and Lilly introduce the My Well Planner Lifestyle Improvement Program for Adults with Type 2 Diabetes
8. Boehringer Ingelheim announces afatinib expanded access program (EAP) for patients with EGFR mutation-positive advanced NSCLC
9. Whistleblowers extraordinary efforts helped win $95 million settlement with Boehringer Ingelheim
10. Phase 2b Data of Boehringer Ingelheims Interferon-Free Hepatitis C Treatment Show Viral Cure Achieved in Up to 85% of Treatment-Naive Patients
11. Boehringer Ingelheim Announces Equine Research Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... 21, 2014  Zacks.com announces the list of stocks featured ... analysts discuss the latest news and events impacting stocks and ... Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH - Free Report ), ... Lilly and Company (NYSE: LLY - Free Report ), ... Inc. (Nasdaq: ITMN - Free Report ). ...
(Date:7/21/2014)... Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... treatments for cancer and its associated pain, today announced ... development of a small molecule inhibitor targeting the important ... protein has also been recognized as an important determinant ... as a dominant factor in most human cancers and ...
(Date:7/21/2014)...  A new Journal of the American Medical ... to appear in the August 13 print edition addresses ... C Virus (HCV) treatments such as Sovaldi (sofosbuvir) and ... (NYSE: CVS ) Chief Medical Officer Troyen ... Shrank , M.D., suggest that the discussion to this ...
Breaking Medicine Technology:The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 2The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 3The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 4The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 5The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 6The Zacks Analyst Blog Highlights: Anthera Pharmaceuticals, Amgen, Eli Lilly, Actelion and InterMune 7Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 2Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 3Sorrento Awarded Grant from the National Institutes of Health for the Development of a Small Molecule Myc Inhibitor 4CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 2CVS Caremark JAMA Commentary: New Hepatitis C Treatments Highlight Need to Control Costs of High-Priced Specialty Medications 3
... INDIANAPOLIS and ROLLING MEADOWS, Ill., April 4, 2012 ... the Diabetes Scholars Foundation (Foundation) scholarship fund. The contribution ... with type 1 diabetes to live their lives to ... fund college scholarships for students with type 1 diabetes ...
... 2012   Sunpeaks Ventures, Inc. (OTCBB: SNPK) ... its wholly owned subsidiary Healthcare Distribution Specialists, LLC ... has entered into an Agreement with Albeck Financial ... Albeck will provide outsourced Chief Financial Officer services, ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Sunpeaks Ventures Announces Agreement with Albeck Financial Services 2
(Date:7/22/2014)... (PRWEB) July 22, 2014 The ... (Short Acting, Intermediate Acting, Premixed), Modern Human Insulin ... Apidra, Levemir, NovoRapid, Novomix, Tresiba, Others) - Forecast ... major drivers, restraints, challenges, opportunities, current market trends, ... along with the estimates and forecasts of the ...
(Date:7/22/2014)... (PRWEB) July 22, 2014 For more ... and cold storage consumers with dynamic, specialized ... and customer satisfaction. Offering 50-70% less energy requirements ... process. This process is completed through a non-chemical ... technologies also provide a 4.2 Micron droplet. The ...
(Date:7/22/2014)... Rockville, Maryland (PRWEB) July 22, 2014 ... partnership with the Immune Deficiency Foundation (IDF) ... and mobile portal that will allow them to electronically ... to better manage their illnesses. It will also allow ... in research, to consent to have their data ...
(Date:7/22/2014)... Altec Products, Inc. , a ... today their Gold Sponsorship of Sage Summit 2014 ... Hotel and Casino in Las Vegas, Nevada. The largest ... interested in taking advantage of the many opportunities to ... problems and educate themselves on the latest enterprise resource ...
(Date:7/22/2014)... Tigrent Learning Canada today announced ... estate investing workshops being held in the greater Toronto, ... introduce people to some of the strategies successful investors ... total of 9 free real estate investing workshops will ... goal is to give people in the greater Toronto ...
Breaking Medicine News(10 mins):Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 2Health News:Smart Fog Inc Announces Cold Storage Humidification Technology to be Exhibited at the 2014 Fresh Summit Convention & Expo 3Health News:Get Real Health to Partner with Immune Deficiency Foundation 2Health News:Get Real Health to Partner with Immune Deficiency Foundation 3Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 2Health News:Altec Announces Gold Sponsorship of Sage Summit 2014 3Health News:Brick Buy Brick Announces Multiple 1-Day Real Estate Workshops Coming to Toronto 2
... of their breasts, can breathe easy now. They can raise ... their photographs . ,Visit www.myFreeimplants.com, set up a ... with other members. ,Once you have uploaded their ... can have a one-on-one chat online with benefactors and sell ...
... pair of legs in show business . ,But a ... hottest legs. ,Girls Aloud singer Nadine Coyle was voted ... ,The English all-girl group member beat other long-legged ladies ... singer Beyonce Knowles bagged the second place while troubled pop star ...
... Actor/producer Kirk Douglas admits that when it came to beautiful women ... ,The 90-year-old revealed that when he was young he ... with her. ,"The young Kirk was too interested in ... Post quoted Douglas, as saying. ,The actor revealed that ...
... law to ban circuses from importing or exporting protected ... rights, a legislator said Friday . ,Under ... imports and exports of animals such as lions, tigers, ... for research, said Tien Chiu-chin, of the ruling Democratic ...
... and money to properly treat a growing number of ... report out Friday . ,"The military system ... adequately support the psychological health of service members and ... year-long Pentagon mental health task force report: "An Achievable ...
... year in Sierra Leone's capital Freetown last year has been ... health worker attributed the fall in rabies cases to a ... the main referral Connaught Hospital are worried about a lack ... hospital has had to rely heavily on anti-rabies drug handouts ...
Cached Medicine News:Health News:Website Offers to Help Women Raise Money for Breast Enhancement 2Health News:War Veterans Lack Adequate Mental Health Care: Pentagon Report 2
... LV lead is designed to ensure ... procedure times, delivering a complete package ... QuickSite LV lead is a highly ... including such features as S-shaped fixation, ...
... Tibial Nail System is designed ... of existing implants and expand ... nails. It is available in ... and lengths and can be ...
Arthroscopic instrument system for instability and SLAP fixation....
Arthroscopic instrument system for instability and SLAP fixation....
Medicine Products: